6 drug(s) with this reaction
14,260 total reports
Loss Of Personal Independence In Daily Activities has been reported as an adverse reaction across 6 drug(s) manufactured by Abbvie Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 14,260 adverse event reports mention loss of personal independence in daily activities in connection with Abbvie Inc products.
This page provides a breakdown of which Abbvie Inc drugs are most commonly associated with loss of personal independence in daily activities, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Abbvie Inc drugs have loss of personal independence in daily activities listed in their FDA adverse event reports, sorted by report count:
In addition to loss of personal independence in daily activities, the following adverse reactions have been reported across Abbvie Inc's drug portfolio:
6 drug(s) manufactured by Abbvie Inc have loss of personal independence in daily activities listed in their FDA adverse event reports: Humira, ADALIMUMAB, UPADACITINIB, LOPINAVIR AND RITONAVIR, RITONAVIR, and others.
There are a combined 14,260 reports of loss of personal independence in daily activities across 6 Abbvie Inc drug(s) in the FDA adverse event database.